2 Experimental Ebola Vaccines Show Promise In Primate Trials

CIDRAP News: Second-generation Ebola vaccines show promise in animal study
“Two candidate Ebola vaccines developed as possible next-generation products fully protected monkeys immunized with a single dose against experimental infection with the strain responsible for West Africa’s outbreak, researchers reported [Wednesday]…” (Schnirring, 4/8).

New York Times: 2 New Ebola Vaccines Pass Important Early Test, Researchers Say
“…The vaccines have not yet been tested in people, but safety trials in healthy volunteers will probably begin early this summer, said Thomas W. Geisbert, an Ebola expert at the University of Texas Medical Branch in Galveston, and the senior author of a report published on Wednesday in the journal Nature…” (Grady, 4/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.